SCHEMBL9257862

SCHEMBL9257862

CC1(C)CCC(C)(C)c2cc(C#Cc3ccc(C=O)cn3)ccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.50
CYP26A1 O43174 5/20 0.50
RARB P10826 12/20 0.49
RARG P13631 12/20 0.49
RARA P10276 10/20 0.49
CRABP2 P29373 1/20 0.49
KMT2A Q03164 1/20 0.48
RXRA P19793 5/20 0.36
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
GMNN O75496 1/20 0.36
USP2 O75604 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
CYP1A2 P05177 1/20 0.36
POLB P06746 1/20 0.36
CYP2D6 P10635 1/20 0.36
NFKB1 P19838 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL180442 0.85 CYP3A4 (0.70) CYP3A4CYP26A1RARBRARGRARA
SCHEMBL6665791 0.84 RARB (0.46) CYP3A4CYP26A1RARBRARGRARA
SCHEMBL9484730 0.84 RARB (0.62) CYP3A4CYP26A1RARBRARGRARA
SCHEMBL19342919 0.81 CYP3A4 (0.49) CYP3A4CYP26A1RARBRARGRARA
SCHEMBL9271106 0.80 RARB (0.49) CYP3A4CYP26A1RARBRARGRARA
SCHEMBL8865723 0.79 CYP3A4 (0.42) CYP3A4CYP26A1RARBRARGRARA
SCHEMBL5084210 0.79 CYP3A4 (0.72) CYP3A4CYP26A1RARBRARGRARA
SCHEMBL9264079 0.79 CYP26A1 (0.54) CYP3A4CYP26A1RARBRARGRARA
SCHEMBL22198810 0.78 RARB (0.51) CYP3A4CYP26A1RARBRARGRARA
SCHEMBL9268548 0.76 RARB (0.46) CYP3A4CYP26A1RARBRARGRARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5466690-A Treating psoriasis ALLERGAN, INC. (US) 1995-11-14 US disclosed
US-5354776-A Treating psoriasis ALLERGAN, INC. (US) 1994-10-11 US disclosed
EP-0284261-B1 Acetylenes disubstituted with a heteroaromatic group and a tetralin group having retinoid like activity ALLERGAN INC (US) 1994-01-05 EP disclosed
US-5246962-A Psoriasis, skin disorders ALLERGAN, INC. (US) 1993-09-21 US disclosed
US-5149705-A Treatment of psoriasis ALLERGAN, INC. (US) 1992-09-22 US disclosed
EP-0284261-A1 Acetylenes disubstituted with a heteroaromatic group and a tetralin group having retinoid like activity ALLERGAN, INC (US) 1988-09-28 EP disclosed